These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12126259)

  • 1. Systolic hypertension as a cardiovascular risk factor.
    McInnes GT
    Blood Press; 2002; 11(3):134-43. PubMed ID: 12126259
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on Hypertension Management: treatment of hypertension in patients with type 2 diabetes mellitus.
    Nilsson PM; Cifkova R; Kjeldsen SE
    J Hypertens; 2006 Jan; 24(1):208-10. PubMed ID: 16331123
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertensiology 2007].
    Middeke M
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1368-70. PubMed ID: 17570082
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive therapy and de-stiffening of the arteries.
    Safar ME; Jankowski P
    Expert Opin Pharmacother; 2010 Nov; 11(16):2625-34. PubMed ID: 20977399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
    Coca A; Ruilope LM
    Med Clin (Barc); 2000 Jul; 115(5):178-80. PubMed ID: 10996874
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal and stroke protection in hypertensive patients at CV risk.
    Cardiovasc J Afr; 2007; 18(5):337, 340. PubMed ID: 17985036
    [No Abstract]   [Full Text] [Related]  

  • 7. The renin-angiotensin system in the twenty-first century.
    Nicholls MG; Robertson JI; Inagami T
    Blood Press; 2001; 10(5-6):327-43. PubMed ID: 11822537
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extracellular matrix proteins and glycoproteins in the cardiovascular system].
    Sasamura H; Saruta T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():559-64. PubMed ID: 16897888
    [No Abstract]   [Full Text] [Related]  

  • 9. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hypertension in diabetes: what is the best therapeutic option?
    Aksnes TA; Skårn SN; Kjeldsen SE
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):727-34. PubMed ID: 22894629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
    Lambers Heerspink HJ; Perkovic V; de Zeeuw D
    J Hypertens; 2009 Dec; 27(12):2321-31. PubMed ID: 19727007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it the the renin-angiotensin-aldosterone blockade a comprehensive tool for the management of cardiovascular risk?
    Borghi C; Grassi G
    J Hypertens; 2004 Mar; 22(3):463-5. PubMed ID: 15076149
    [No Abstract]   [Full Text] [Related]  

  • 14. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A; Redón J
    Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review.
    Ferrari R; Boersma E
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):705-17. PubMed ID: 23750680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive pharmacological agents: beyond their lowering blood pressure effects.
    Miatello RM
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):521-3. PubMed ID: 16309575
    [No Abstract]   [Full Text] [Related]  

  • 17. The renin-angiotensin system antagonism in the treatment of hypertension.
    Bisognano JD; Cody RJ
    Curr Hypertens Rep; 1999 Aug; 1(4):275-7. PubMed ID: 10981078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
    Tempelhof MW
    South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension therapy and cardiovascular protection. Effects of angiotensin II receptor block with Valsartan.
    Sestito A
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1247-55. PubMed ID: 22195356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.